Showing results (461-470 of 476) with videos related to
Sort By:
Pageof 48
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2020
A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory TractFrancisco M Marty, Roy F Chemaly, Kathleen M Mullane, et al.Blood Research|April 2, 2015
SOCS1 and SOCS3 are expressed in mononuclear cells in human cytomegalovirus viremia after allogeneic hematopoietic stem cell transplantationSeung-Hwan Shin, Ji Yoon Lee, Tae Hyang Lee, et al.Infection & Chemotherapy|July 3, 2024
Recommendations for Adult Immunization by the Korean Society of Infectious Diseases, 2023: Minor Revisions to the 3rd EditionWon Suk Choi, Joon Young Song, Ki Tae Kwon, et al.Antimicrobial Agents and Chemotherapy|February 5, 2020
Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell TransplantationJohan Maertens, Aaron C Logan, Junho Jang, et al.Annals of Hematology|November 27, 2012
Impact of cytomegalovirus gastrointestinal disease on the clinical outcomes in patients with gastrointestinal graft-versus-host disease in the era of preemptive therapyByung-Sik Cho, Seung-Ah Yahng, Jung-Ho Kim, et al.Plos One|March 10, 2017
The demanding attention of tuberculosis in allogeneic hematopoietic stem cell transplantation recipients: High incidence compared with general populationHyo-Jin Lee, Dong-Gun Lee, Su-Mi Choi, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Wilms tumor gene 1 expression as a predictive marker for relapse and survival after hematopoietic stem cell transplantation for myelodysplastic syndromesJae-Ho Yoon, Young-Woo Jeon, Seung-Ah Yahng, et al.Journal of Korean Medical Science|January 17, 2014
Success rate and risk factors for failure of empirical antifungal therapy with itraconazole in patients with hematological malignancies: a multicenter, prospective, open-label, observational study in KoreaSoo-Jeong Kim, June-Won Cheong, Yoo Hong Min, et al.Lancet (London, England)|December 20, 2015
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trialJohan A Maertens, Issam I Raad, Kieren A Marr, et al.JAMA|July 10, 2019
Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical TrialAdriana Bastidas, Javier de la Serna, Mohamed El Idrissi, et al.Pageof 48